Cargando…

Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing

A major class of bispecific antibodies (BsAbs) utilizes heterodimeric Fc to produce the native immunoglobulin G (IgG) structure. Because appropriate pairing of heavy and light chains is required, the design of BsAbs produced through recombination or reassembly of two separately-expressed antigen-bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiba, Hiroki, Ise, Tomoko, Nagata, Satoshi, Kamada, Haruhiko, Ohno, Hiroaki, Tsumoto, Kouhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484483/
https://www.ncbi.nlm.nih.gov/pubmed/34593913
http://dx.doi.org/10.1038/s41598-021-98855-3
_version_ 1784577328203956224
author Akiba, Hiroki
Ise, Tomoko
Nagata, Satoshi
Kamada, Haruhiko
Ohno, Hiroaki
Tsumoto, Kouhei
author_facet Akiba, Hiroki
Ise, Tomoko
Nagata, Satoshi
Kamada, Haruhiko
Ohno, Hiroaki
Tsumoto, Kouhei
author_sort Akiba, Hiroki
collection PubMed
description A major class of bispecific antibodies (BsAbs) utilizes heterodimeric Fc to produce the native immunoglobulin G (IgG) structure. Because appropriate pairing of heavy and light chains is required, the design of BsAbs produced through recombination or reassembly of two separately-expressed antigen-binding fragments is advantageous. One such method uses intein-mediated protein trans-splicing (IMPTS) to produce an IgG1-based structure. An extra Cys residue is incorporated as a consensus sequence for IMPTS in successful examples, but this may lead to potential destabilization or disturbance of the assay system. In this study, we designed a BsAb linked by IMPTS, without the extra Cys residue. A BsAb binding to both TNFR2 and CD30 was successfully produced. Cleaved side product formation was inevitable, but it was minimized under the optimized conditions. The fine-tuned design is suitable for the production of IgG-like BsAb with high symmetry between the two antigen-binding fragments that is advantageous for screening BsAbs.
format Online
Article
Text
id pubmed-8484483
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84844832021-10-04 Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing Akiba, Hiroki Ise, Tomoko Nagata, Satoshi Kamada, Haruhiko Ohno, Hiroaki Tsumoto, Kouhei Sci Rep Article A major class of bispecific antibodies (BsAbs) utilizes heterodimeric Fc to produce the native immunoglobulin G (IgG) structure. Because appropriate pairing of heavy and light chains is required, the design of BsAbs produced through recombination or reassembly of two separately-expressed antigen-binding fragments is advantageous. One such method uses intein-mediated protein trans-splicing (IMPTS) to produce an IgG1-based structure. An extra Cys residue is incorporated as a consensus sequence for IMPTS in successful examples, but this may lead to potential destabilization or disturbance of the assay system. In this study, we designed a BsAb linked by IMPTS, without the extra Cys residue. A BsAb binding to both TNFR2 and CD30 was successfully produced. Cleaved side product formation was inevitable, but it was minimized under the optimized conditions. The fine-tuned design is suitable for the production of IgG-like BsAb with high symmetry between the two antigen-binding fragments that is advantageous for screening BsAbs. Nature Publishing Group UK 2021-09-30 /pmc/articles/PMC8484483/ /pubmed/34593913 http://dx.doi.org/10.1038/s41598-021-98855-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Akiba, Hiroki
Ise, Tomoko
Nagata, Satoshi
Kamada, Haruhiko
Ohno, Hiroaki
Tsumoto, Kouhei
Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
title Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
title_full Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
title_fullStr Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
title_full_unstemmed Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
title_short Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
title_sort production of igg1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484483/
https://www.ncbi.nlm.nih.gov/pubmed/34593913
http://dx.doi.org/10.1038/s41598-021-98855-3
work_keys_str_mv AT akibahiroki productionofigg1basedbispecificantibodywithoutextracysteineresidueviainteinmediatedproteintranssplicing
AT isetomoko productionofigg1basedbispecificantibodywithoutextracysteineresidueviainteinmediatedproteintranssplicing
AT nagatasatoshi productionofigg1basedbispecificantibodywithoutextracysteineresidueviainteinmediatedproteintranssplicing
AT kamadaharuhiko productionofigg1basedbispecificantibodywithoutextracysteineresidueviainteinmediatedproteintranssplicing
AT ohnohiroaki productionofigg1basedbispecificantibodywithoutextracysteineresidueviainteinmediatedproteintranssplicing
AT tsumotokouhei productionofigg1basedbispecificantibodywithoutextracysteineresidueviainteinmediatedproteintranssplicing